Ignite Creation Date:
2024-05-06 @ 12:47 AM
Last Modification Date:
2024-10-26 @ 10:54 AM
Study NCT ID:
NCT01658462
Status:
COMPLETED
Last Update Posted:
2019-05-31
First Post:
2012-07-31
Brief Title:
Phase II Study of Docetaxel - Nintedanib in Breast Cancer
Sponsor:
Centre Oscar Lambret
Organization:
Centre Oscar Lambret
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05
Start Date Type:
None
Primary Completion Date:
2016-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-30
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-31
First Submit QC Date:
August 6 2012
Study First Post Date:
2012-08-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-29
Last Update Post Date:
2019-05-31
Last Update Post Date Type:
ACTUAL